InsiderTrades

Form 4 for DTIL PRECISION BIOSCIENCES INC

Accepted 2026-02-19 00:00:00 ET · period of report 2026-02-17 · accession 0001628280-26-009803 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2026-02-19 2026-02-18 DTIL Kelly John Alexander CFO S - Sale+OE $3.84 -8,149 125.9K -6% -$31.3K
D 2026-02-19 2026-02-17 DTIL Kelly John Alexander CFO M - OptEx $0.00 +27.6K 134.0K +26% $0
D 2026-02-19 2026-02-17 DTIL Kelly John Alexander CFO M - OptEx $0.00 -27.6K 55.2K -33% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-02-18 S D 8,149 $3.84 125,883 D — —
2 Common Common Stock 2026-02-17 M A 27,584 $0.00 134,032 D — — (F1) Represents the vesting of Restricted Stock Units ("RSUs") on February 17, 2026. (F2) Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
3 Derivative Restricted Stock Units 2026-02-17 M D 27,584 $0.00 55,166 D — · — to — 27,584 Common Stock (F2) Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. (F4) RSUs vests in three substantially equal annual installments beginning on February 17, 2026, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.